TriSalus Life Sciences, Inc. (TLSI) AI Dilution Summary

TLSI reported cash of $46,288,000 at the 2026-06-30 balance-sheet date, against estimated monthly burn of $3,376,333; its registered funding channel is an active S-3 shelf. Dilution here is driven primarily by S-3 shelf 333-291509, registered to $150,000,000, with $46,000,011.50 used to date and $103,999,988.50 remaining, expiring 2028-12-04. Because its capacity is stated in dollars, the number of shares a takedown can issue rises as the share price falls.